Author

Tobias Gedde‐Dahl

Oslo University HospitalORCID 0000-0002-3037-5378Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Anders Theodor Aasebo· 1 shared Bjørn Tore GjertseniD· 1 shared Brian K. ChungiD· 1 shared Diana DomańskaiD· 1 shared Dominik Georg Friedrich WolfiD· 1 shared Erin Craig· 1 shared Espen S. BækkevoldiD· 1 shared F.L. Jahnsen· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anders Theodor Aasebo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyBeneficial MicrobesPeer-reviewedMay 11, 2026

Ultra long-lived plasma cells in the human small intestine produce microbiota-reactive IgA antibodies

Niladri Bhusan Pati, Brian K. Chung, Kristian Holm…·F.L. Jahnsen

The paper identifies ultra long-lived plasma cells in the human small intestine that produce IgA antibodies reactive to a diverse microbiota, suggesting long-term immune memory shaping the microbiome.

DOI 10.1163/18762891-bja00120

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 10, 2025

Deep single-cell immune and signaling profiles predict long term therapy response in chronic myeloid leukemia within hours

Stein‐Erik Gullaksen, Mathias Brevik, Øystein Sefland…·Bjørn Tore Gjertsen

The paper uses mass cytometry to analyze immune and signaling profiles in CML patients within hours of TKI treatment to predict 12-month treatment response.

DOI 10.1101/2025.11.10.687542

humanflow cytometry

𝕏 PostBluesky